American Journal of Clinical Nutrition, Vol 52, 300-306, Copyright © 1990 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Fish-oil concentrate: effects on variables related to cardiovascular disease

H Flaten, AT Hostmark, P Kierulf, E Lystad, K Trygg, T Bjerkedal and A Osland
Occupational Health Office, Oslo Transport, Norway.

Sixty-four male, healthy volunteers aged 35-45 y were randomly assigned to receive (as 1-g capsules) either 14 g fish-oil concentrate/d (55% n- 3 fatty acids) or 14 g olive oil/d for 6 wk. Plasma fibrinogen was reduced by 13% and serum triglycerides by 22% after fish-oil supplementation ended. Three weeks after supplementation ended both variables were back to baseline values. An appreciable increase in the ratio of eicosapentaenoic acid to arachidonic acid (EPA:AA) in plasma eicosapentaenoic acid to arachidonic acid (EPA:AA) in plasma and red blood cell phospholipids occurred during the fish-oil intake. High- density-lipoprotein (HDL) cholesterol and HDL2 activity tended to be lowered by fish-oil supplementation. Systolic and diastolic blood pressures, serum cholesterol, gamma-glutamyltransferase, blood glucose, and monocyte low-density-lipoprotein receptor activity did not differ significantly between the two groups. The reduction in plasma fibrinogen concentration seems of special interest because this variable in several recent studies emerges as a separate cardiovascular risk factor with a high predictive value.

This article has been cited by other articles:

				J. A Lovegrove, S. S Lovegrove, S. V. Lesauvage, L. M Brady, N. Saini, A. M Minihane, and C. M Williams Moderate fish-oil supplementation reverses low-platelet, long-chain n-3 polyunsaturated fatty acid status and reduces plasma triacylglycerol concentrations in British Indo-Asians Am. J. Clinical Nutrition, June 1, 2004; 79(6): 974 - 982. [Abstract] [Full Text] [PDF]

				E. D. Schlenker The Evolution of Research in Family and Consumer Sciences: Food, Nutrition, and Health Family and Consumer Sciences Research Journal, December 1, 2001; 30(2): 140 - 196. [Abstract] [PDF]

				E. Dewailly, C. Blanchet, S. Lemieux, L. Sauve, S. Gingras, P. Ayotte, and B. J. Holub n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik Am. J. Clinical Nutrition, October 1, 2001; 74(4): 464 - 473. [Abstract] [Full Text] [PDF]

				R. De Caterina and G. Basta n-3 Fatty acids and the inflammatory response -- biological background Eur. Heart J. Suppl., June 1, 2001; 3(suppl_D): D42 - D49. [Abstract] [PDF]

				L. J. Appel, E. R. Miller III, A. J. Seidler, and P. K. Whelton Does Supplementation of Diet With 'Fish Oil' Reduce Blood Pressure? A Meta-analysis of Controlled Clinical Trials Arch Intern Med, June 28, 1993; 153(12): 1429 - 1438. [Abstract] [PDF]

				National High Blood Pressure Education Program Working Group Report on Primary Prevention of Hypertension Arch Intern Med, January 25, 1993; 153(2): 186 - 208. [Abstract] [PDF]

				M. M. Gottschlich Invited Review: Selection of Optimal Lipid Sources in Enteral and Parenteral Nutrition Nutr Clin Pract, August 1, 1992; 7(4): 152 - 165. [Abstract] [PDF]

				The Trials of Hypertension Prevention Collaborativ, Members of the Trials of Hypertension Prevention C, Clinical Centers, P. K. Whelton, L. Appel, J. Charleston, A. T. Dalcin, C. Ewart, L. Fried, D. Kaidy, et al. The Effects of Nonpharmacologic Interventions on Blood Pressure of Persons With High Normal Levels: Results of the Trials of Hypertension Prevention, Phase I JAMA, March 4, 1992; 267(9): 1213 - 1220. [Abstract] [PDF]